Cabotegravir news

All news on Cabotegravir (also known as Apretude and Vocabria): plants, production capacities, investments and involved companies.

16 March 2026

Neste Advocates Strong Anti-Fraud Measures in Biofuels Supply Chains

Neste emphasizes rigorous supplier audits, traceability, and collaboration to combat fraud in renewable raw materials, ensuring compliance and authenticity in its supply chains.
25 February 2026

ViiV Healthcare: Lotivibart Shows 94% Viral Suppression in Long-Acting HIV Treatment

Lotivibart, combined with CAB LA, maintained viral suppression in 94% of participants. Study progresses to test twice-yearly dosing. Well-tolerated with fewer adverse events in IV group.

Who will be producing Cabotegravir in the future?

Find out with chemXplore Alpha

Learn more